BIJUVA®, le seul THS bioidentique, combinant estradiol et progestérone dans une seule pilule: enfin disponible en Belgique, après les EU (approbation en 2018 par la Food and Drug Administration) !
Bijuva® is intended for the « natural» treatment of estrogen deficiency symptoms. It combines the two bioidentical female hormones (progesterone P4 and estradiol E2) in low doses into a single capsule. It is taken in the evening, promoting falling asleep and improving sleep disorders. The phase 3 trial, REPLENISH, randomized double-blind versus placebo-controlled, demonstrated good effectiveness on vasomotor symptoms and quality of life, as well as, over one year, its endometrial safety (no endometrial hyperplasia). Bijuva® is a non-stop continuous combination drug that minimizes blood loss an... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | Artikel |
Erscheinungsdatum: | 2022 |
Schlagwörter: | Sciences bio-médicales et agricoles / bioidentical hormones / endometrial hyperplasia / estradiol / hormone replacement treatment (HRT) / progesterone |
Sprache: | Französisch |
Permalink: | https://search.fid-benelux.de/Record/base-27336615 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/346884 |